Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

27. Juni 2011 08:00 ET | Quelle: Atossa Genetics, Inc.

Atossa Genetics Completes $6.6 Million Over-Subscribed Private Placement

SEATTLE, WA--(Marketwire - Jun 27, 2011) - Atossa Genetics, Inc., a privately-held health care company focused on the development and marketing of novel cellular and molecular diagnostic risk...
24. Mai 2011 08:00 ET | Quelle: Atossa Genetics, Inc.

Atossa Genetics Announces Licensing of Its New National Reference Laboratory for Breast Health

SEATTLE, WA--(Marketwire - May 24, 2011) - Atossa Genetics, Inc., a privately-held health care company focused on the development and marketing of novel cellular and molecular diagnostic risk...
03. Mai 2011 08:30 ET | Quelle: Atossa Genetics, Inc.

Atossa Genetics, Inc. and HLB, LLC Announce Partnership to Manufacture Atossa's Patented, FDA-Cleared MASCT System for Breast Cancer Risk Assessment

SEATTLE, WA and CHICAGO, IL--(Marketwire - May 3, 2011) - Atossa Genetics, Inc., a privately-held health care company focused on the development and marketing of novel cellular and molecular...
14. April 2011 11:28 ET | Quelle: Atossa Genetics, Inc.

Atossa Genetics Appoints Tim Hunkapiller, Ph.D., to Its Scientific Advisory Board

SEATTLE, WA--(Marketwire - Apr 14, 2011) - Atossa Genetics, Inc., a privately-held health care company focused on the development and marketing of novel cellular and molecular diagnostic risk...
14. März 2011 08:00 ET | Quelle: Atossa Genetics, Inc.

Steven C. Quay, M.D., Ph.D., of Atossa Genetics Elected as a Fellow of the College of American Pathologists

SEATTLE, WA--(Marketwire - March 14, 2011) - Atossa Genetics, Inc., a privately-held health care company focused on the development and marketing of novel cellular and molecular diagnostic risk...
04. März 2011 08:30 ET | Quelle: Atossa Genetics, Inc.

Seattle Business Magazine Recognizes Steven C. Quay, M.D., Ph.D., of Atossa Genetics, Inc., as One of the Pacific Northwest's Top Leaders in Health Care

SEATTLE, WA--(Marketwire - March 4, 2011) - Atossa Genetics, Inc., a privately-held health care company focused on the development and marketing of novel cellular and molecular diagnostic risk...
01. Oktober 2010 09:30 ET | Quelle: Atossa Genetics, Inc.

Atossa Genetics, Inc. Announces Filing of S-1 Registration Statement

SEATTLE, WA--(Marketwire - October 1, 2010) - Atossa Genetics, Inc., a privately-held healthcare company focused on the development and marketing of novel cellular and molecular diagnostic risk...
25. Mai 2010 09:00 ET | Quelle: Atossa Genetics, Inc.

Atossa Genetics, Inc. Appoints Robert L. Kelly as President

SEATTLE, WA--(Marketwire - May 25, 2010) - Atossa Genetics, Inc., a privately-held healthcare company focused on the development and marketing of leading edge and unique cellular and molecular...
25. Februar 2010 11:00 ET | Quelle: Atossa Genetics, Inc.

Atossa Genetics, Inc. Appoints Edward Sauter, M.D., Ph.D., to Its Scientific Advisory Board

SEATTLE, WA--(Marketwire - February 25, 2010) - Atossa Genetics, Inc., a privately-held healthcare company focused on the development and marketing of novel cellular and molecular diagnostic...
08. Februar 2010 08:30 ET | Quelle: Atossa Genetics, Inc.

Atossa Genetics, Inc. Launches Corporate Web Site Featuring New FDA-Approved Breast Cancer Risk Assessment Test

SEATTLE, WA--(Marketwire - February 8, 2010) - Atossa Genetics, Inc., a privately-held healthcare company focused on the development and marketing of novel cellular and molecular diagnostic...

Vorherige Seite